Exhibit 10.1
Execution Version
AMENDMENT NO. 3 TO CREDIT AGREEMENT
     This Amendment No. 3 to Credit Agreement dated as of September 18, 2007
(this “Amendment”), is made by and among PEDIATRIX MEDICAL GROUP, INC., a
Florida corporation (the “Company”), certain of its subsidiaries and affiliates
(together with the Company, collectively, the “Borrowers”), BANK OF AMERICA,
N.A. in its capacity as administrative agent (in such capacity, the
“Administrative Agent”) under the Credit Agreement described below, and each of
the Lenders signatory hereto.
RECITALS:
     A. The Borrowers, the Administrative Agent and the lenders from time to
time party thereto (the “Lenders”) have entered into that certain Credit
Agreement dated as of July 30, 2004 (as amended by that certain Amendment No. 1
to Credit Agreement dated January 11, 2005 and that certain Amendment No. 2 to
Credit Agreement dated March 10, 2005, the “Credit Agreement”), pursuant to
which the Lenders have made available to the Borrowers a revolving credit
facility. Capitalized terms used in this Amendment not otherwise defined herein
shall have the definitions given thereto in the Credit Agreement.
     B. The Borrowers have requested to amend the Credit Agreement as set forth
below and the Administrative Agent and the Lenders signatory hereto are willing
to effect such amendment on the terms and conditions set forth herein.
     In furtherance of the foregoing and for valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as
follows:
     1. Amendment to Credit Agreement. Subject to the terms and conditions set
forth herein, Section 7.06 of the Credit Agreement is hereby deleted in its
entirety and the following is inserted in lieu thereof:
     7.06 Acquisitions. Enter into any Acquisition Agreement, or take any action
to solicit the tender of securities or proxies in respect thereof in order to
effect any Acquisition, unless either (a) the aggregate amount of the Costs of
Acquisition and Earnout Payments with respect to such Acquisition does not
exceed $5,000,000, or (b) each of the following conditions is satisfied: (i) the
Person to be (or whose assets are to be) acquired does not oppose such
Acquisition (other than in the case of an Acquisition pursuant to a Holder
Purchase Grant) and has Permitted Acquisition EBITDA for the most recently ended
twelve-month period of not less than $1, (ii) the line or lines of business of
the Person to be acquired are substantially the same as one or more line or
lines of business conducted by the Company and its Subsidiaries, (iii) the
operations of the Person to be (or whose assets are to be) acquired are
primarily in the United States or its territories, (iv) no Default shall have
occurred and be continuing either immediately prior to or immediately after
giving effect to such Acquisition and the Company shall have furnished to the
Administrative Agent a Compliance Certificate prepared on an

1

--------------------------------------------------------------------------------

 

historical pro forma basis as of the most recent date for which financial
statements have been furnished pursuant to Section 4.01 or Section 6.01(a) or
(b) giving effect to such Acquisition, which certificate shall demonstrate that
no Default would exist immediately after giving effect thereto, (v) the Person
acquired shall be a wholly-owned Subsidiary, or be merged into a Borrower,
immediately upon consummation of the Acquisition (or if assets are being
acquired, the acquiror shall be a wholly-owned Subsidiary or a Borrower),
(vi) after giving effect to such Acquisition, the aggregate Costs of Acquisition
and Earnout Payments incurred in any fiscal year of the Company (on a
noncumulative basis, with the effect that amounts not incurred in any fiscal
year may not be carried forward to a subsequent period) shall not exceed
$200,000,000, of which not more than $20,000,000 shall be in connection with an
Acquisition of a Person (or the assets of a Person) whose operations are
primarily in a territory of the United States, and (vii) after giving effect to
such Acquisition, the aggregate Costs of Acquisition and Earnout Payments
incurred since the Closing Date in connection with Acquisitions of Persons (or
the assets of Persons) whose operations are primarily in one or more territories
of the United States shall not exceed $50,000,000.
     2. Effectiveness; Conditions Precedent. The effectiveness of this Amendment
is subject to the satisfaction of the following conditions precedent:
     (a) the Administrative Agent shall have received an original or facsimile
(promptly followed by originals) executed counterpart of this Amendment, duly
executed by each Borrower, the Administrative Agent and the Required Lenders;
and
     (b) all fees and expenses payable to the Administrative Agent and the
Lenders (including the fees and expenses of counsel to the Administrative Agent)
invoiced to date shall have been paid in full.
     3. Consent and Continued Enforceability. Each Borrower hereby consents,
acknowledges and agrees to the amendments set forth herein and hereby confirms
and ratifies in all respects its obligations under the Credit Agreement and each
other Loan Document (including without limitation the continuation of such
Borrower’s payment and performance obligations thereunder upon and after the
effectiveness of this Amendment and the amendments contemplated hereby) and the
enforceability of each such Loan Document against such Borrower in accordance
with its terms.
     4. Representations and Warranties. In order to induce the Administrative
Agent and the Lenders to enter into this Amendment, each Borrower represents and
warrants to the Administrative Agent and the Lenders as follows:
     (a) The representations and warranties made by each Borrower in Article V
of the Credit Agreement and in each of the other Loan Documents to which such
Borrower is a party are true and correct on and as of the date hereof, except to
the extent that such representations and warranties expressly relate to an
earlier date, and except that for purposes of this Section 4, the
representations and warranties contained in subsections (a) and (b) of
Section 5.05 of the Credit Agreement shall be deemed to refer to the most

2

--------------------------------------------------------------------------------

 

recent statements furnished pursuant to clauses (a) and (b), respectively, of
Section 6.01 of the Credit Agreement;
     (b) Other than the matters set forth on Schedule 5.06 of the Credit
Agreement, since the date of the Audited Financial Statements, there has been no
event or circumstance, either individually or in the aggregate, that has had or
could reasonably be expected to have a Material Adverse Effect;
     (c) The Persons appearing as Borrowers on the signature pages to this
Amendment constitute all Persons who are required to be Borrowers pursuant to
the terms of the Credit Agreement and the other Loan Documents, including
without limitation all Persons who became Material Subsidiaries or were
otherwise required to become Borrowers after the Closing Date, and each of such
Persons has become and remains a party to the Credit Agreement as a Borrower;
     (d) This Amendment has been duly authorized, executed and delivered by the
Borrowers party hereto and constitutes a legal, valid and binding obligation of
such parties, except as may be limited by general principles of equity or by the
effect of any applicable bankruptcy, insolvency, reorganization, moratorium or
similar law affecting creditors’ rights generally; and
     (e) No Default or Event of Default has occurred and is continuing.
     5. Entire Agreement. This Amendment, together with all the Loan Documents
(collectively, the “Relevant Documents”), sets forth the entire understanding
and agreement of the parties hereto in relation to the subject matter hereof and
supersedes any prior negotiations and agreements among the parties relating to
such subject matter. No promise, condition, representation or warranty, express
or implied, not set forth in the Relevant Documents shall bind any party hereto,
and no such party has relied on any such promise, condition, representation or
warranty. Each of the parties hereto acknowledges that, except as otherwise
expressly stated in the Relevant Documents, no representations, warranties or
commitments, express or implied, have been made by any party to the other. None
of the terms or conditions of this Amendment may be changed, modified, waived or
canceled orally or otherwise, except in writing and in accordance with
Section 10.01 of the Credit Agreement.
     6. Full Force and Effect of Amendment. Except as hereby specifically
amended, the Credit Agreement and all other Loan Documents are hereby confirmed
and ratified in all respects and shall be and remain in full force and effect
according to their respective terms.
     7. Counterparts. This Amendment may be executed in any number of
counterparts, each of which shall be deemed an original as against any party
whose signature appears thereon, and all of which shall together constitute one
and the same instrument. Delivery of an executed counterpart of a signature page
of this Amendment by telecopy shall be effective as delivery of a manually
executed counterpart of this Amendment.
     8. Governing Law. This Amendment shall in all respects be governed by, and
construed in accordance with, the laws of the State of New York applicable to
contracts executed

3

--------------------------------------------------------------------------------

 

and to be performed entirely within such State, and shall be further subject to
the provisions of Sections 10.14 and 10.15 of the Credit Agreement.
     9. Enforceability. Should any one or more of the provisions of this
Amendment be determined to be illegal or unenforceable as to one or more of the
parties hereto, all other provisions nevertheless shall remain effective and
binding on the parties hereto.
     10. References. All references in any of the Loan Documents to the “Credit
Agreement” shall mean the Credit Agreement, as amended hereby.
     11. Successors and Assigns. This Amendment shall be binding upon and inure
to the benefit of the Borrowers, the Administrative Agent and the Lenders, and
their respective successors, legal representatives, and assignees to the extent
such assignees are permitted assignees as provided in Section 10.06 of the
Credit Agreement.
[Signature pages follow.]

4

--------------------------------------------------------------------------------

 

     IN WITNESS WHEREOF, the parties hereto have caused this instrument to be
made, executed and delivered by their duly authorized officers as of the day and
year first above written.

            BORROWERS:

PEDIATRIX MEDICAL GROUP, INC., a Florida Corporation
      By:   /s/ Karl B. Wagner         Name:   Karl B. Wagner        Title:  
Chief Financial Officer     

     
 
  ALASKA NEONATOLOGY ASSOCIATES, INC.
 
  ASSOCIATES IN NEONATOLOGY, INC.
 
  AUGUSTA NEONATOLOGY ASSOCIATES, P.C.
 
  BNA ACQUISITION COMPANY, INC.
 
  CENTRAL OKLAHOMA NEONATOLOGY ASSOCIATES, INC.
 
  CNA ACQUISITION CORP.
 
  FLORIDA REGIONAL NEONATAL ASSOCIATES, INC.
 
  FOOTHILL MEDICAL GROUP, INC.
 
  FORT WORTH NEONATAL ASSOCIATES BILLING, INC.
 
  GNPA ACQUISITION COMPANY, INC.
 
  MAGELLA HEALTHCARE CORPORATION
 
  MAGELLA HEALTHCARE GROUP, L.P.
 
  MAGELLA MEDICAL ASSOCIATES BILLING, INC.
 
  MAGELLA MEDICAL ASSOCIATES MIDWEST, P.C.
 
  MAGELLA MEDICAL ASSOCIATES OF GEORGIA, P.C.
 
  MAGELLA MEDICAL GROUP, INC.
 
  MAGELLA NEVADA, LLC
 
  MAGELLA TEXAS, LLC

                  By:   /s/ Karl B. Wagner         Name:   Karl B. Wagner       
Title:   Attorney-in-Fact     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

     
 
  MNPC ACQUISITION COMPANY, INC.
 
  MOUNTAIN STATES NEONATOLOGY, INC.
 
  NACF ACQUISITION COMPANY, INC.
 
  NEONATAL AND PEDIATRIC INTENSIVE CARE MEDICAL
    GROUP, INC.
 
  NEONATOLOGY ASSOCIATES BILLING, INC.
 
  NEONATAL SPECIALISTS, LTD.
 
  NSPA ACQUISITION COMPANY, INC.
 
  OBSTETRIX ACQUISITION COMPANY OF ARIZONA, INC.
 
  OBSTETRIX ACQUISITION COMPANY OF COLORADO, INC.
 
  OBSTETRIX MEDICAL GROUP OF ARIZONA, P.C.
 
  OBSTETRIX MEDICAL GROUP OF CALIFORNIA, A
    PROFESSIONAL CORPORATION
 
  OBSTETRIX MEDICAL GROUP OF COLORADO, P.C.
 
  OBSTETRIX MEDICAL GROUP OF KANSAS AND MISSOURI,
    P.A.
 
  OBSTETRIX MEDICAL GROUP OF PHOENIX, P.C.
 
  OBSTETRIX MEDICAL GROUP OF TEXAS BILLING, INC.
 
  OBSTETRIX MEDICAL GROUP OF WASHINGTON, INC., P.S.
 
  OBSTETRIX MEDICAL GROUP, INC.
 
  OZARK NEONATAL ASSOCIATES, INC.
 
  PALM BEACH NEO ACQUISITIONS, INC.
 
  PASCV ACQUISITION COMPANY, INC.
 
  PEDIATRIX ACQUISITION COMPANY OF OHIO, INC.
 
  PEDIATRIX ACQUISITION COMPANY OF WASHINGTON, INC.
 
  PEDIATRIX FLORIDA LLC

                  By:   /s/ Karl B. Wagner         Name:   Karl B. Wagner       
Title:   Attorney-in-Fact     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

     
 
  PEDIATRIX MEDICAL GROUP NEONATOLOGY AND
    PEDIATRIC INTENSIVE CARE SPECIALISTS OF NEW YORK,
    P.C.
 
  PEDIATRIX MEDICAL GROUP OF ARKANSAS, P.A.
 
  PEDIATRIX MEDICAL GROUP OF CALIFORNIA, A
    PROFESSIONAL CORPORATION
 
  PEDIATRIX MEDICAL GROUP OF COLORADO, P.C.
 
  PEDIATRIX MEDICAL GROUP OF FLORIDA, INC.
 
  PEDIATRIX MEDICAL GROUP OF GEORGIA, P.C.
 
  PEDIATRIX MEDICAL GROUP OF ILLINOIS, P.C.
 
  PEDIATRIX MEDICAL GROUP OF INDIANA, P.C.
 
  PEDIATRIX MEDICAL GROUP OF KANSAS, P.A.
 
  PEDIATRIX MEDICAL GROUP OF KENTUCKY, P.S.C.
 
  PEDIATRIX MEDICAL GROUP OF LOUISIANA, L.L.C.
 
  PEDIATRIX MEDICAL GROUP OF MICHIGAN, P.C.
 
  PEDIATRIX MEDICAL GROUP OF MISSOURI, P.C.
 
  PEDIATRIX MEDICAL GROUP OF NEW MEXICO, P.C.
 
  PEDIATRIX MEDICAL GROUP OF NORTH CAROLINA, P.C.
 
  PEDIATRIX MEDICAL GROUP OF OHIO CORP.
 
  PEDIATRIX MEDICAL GROUP OF OKLAHOMA, P.C.

                  By:   /s/ Karl B. Wagner         Name:   Karl B. Wagner       
Title:   Attorney-in-Fact     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

     
 
  PEDIATRIX MEDICAL GROUP OF PENNSYLVANIA, P.C.
 
  PEDIATRIX MEDICAL GROUP OF PUERTO RICO, P.S.C.
 
  PEDIATRIX MEDICAL GROUP OF SOUTH CAROLINA, P.A.
 
  PEDIATRIX MEDICAL GROUP OF TENNESSEE, P.C.
 
  PEDIATRIX MEDICAL GROUP OF TEXAS BILLING, INC.
 
  PEDIATRIX MEDICAL GROUP OF WASHINGTON, INC., P.S.
 
  PEDIATRIX MEDICAL GROUP, INC., a Utah corporation
 
  PEDIATRIX MEDICAL GROUP, P.A.
 
  PEDIATRIX MEDICAL GROUP, P.C., a Virginia corporation
 
  PEDIATRIX MEDICAL GROUP, P.C., a West Virginia corporation
 
  PEDIATRIX MEDICAL MANAGEMENT, L.P.
 
  PEDIATRIX MEDICAL SERVICES, INC.
 
  PEDIATRIX OF MARYLAND, P.A.
 
  PEDIATRIX SCREENING, INC.
 
  PEDIATRIX TEXAS I LLC
 
  PEDIATRIX VIRGINIA ACQUISITION COMPANY, INC.
 
  PERINATAL PEDIATRICS, P.A.
PMGSC, P.A.
 
  PNA ACQUISITION CO., INC.
 
  POKROY MEDICAL GROUP OF NEVADA, LTD.
 
  RPNA ACQUISITION COMPANY, INC.
 
  SCPMC ACQUISITION CO.
 
  SNCA ACQUISITION COMPANY, INC.
 
  ST. JOSEPH NEONATOLOGY CONSULTANTS, INC.

                  By:   /s/ Karl B. Wagner         Name:   Karl B. Wagner       
Title:   Attorney-in-Fact     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

     
 
  TEXAS MATERNAL FETAL MEDICINE BILLING, INC.

 
  TEXAS NEWBORN SERVICES, INC.

 
  TUCSON PERINATAL SERVICES, P.C.

                  By:   /s/ Karl B. Wagner         Name:   Karl B. Wagner       
Title:   Attorney-in-Fact     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            ADMINISTRATIVE AGENT:

BANK OF AMERICA, N.A., as Administrative Agent
                       

                  By:   /s/ Alysa Trakas         Name:   Alysa Trakas       
Title:   Vice President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            LENDERS:

BANK OF AMERICA, N.A. as a Lender, L/C Issuer
and Swing Line Lender
      By:   /s/ Alysa Trakas         Name:   Alysa Trakas        Title:   Vice
President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            HSBC BANK USA, NATIONAL ASSOCIATION
      By:   /s/ Jose M. Cruz         Name:   Jose M. Cruz        Title:   Senior
Vice President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            SUNTRUST BANK
      By:   /s/ Helen C. Hartz         Name:   Helen C. Hartz        Title:  
Vice President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            U.S. BANK NATIONAL ASSOCIATION
      By:   /s/ S. Walker Choppin         Name:   S. Walker Choppin       
Title:   Senior Vice President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            WACHOVIA BANK, N.A.
      By:   /s/ Aly Heimovics         Name:   Aly Heimovics        Title:   Vice
President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            KEYBANK NATIONAL ASSOCIATION
      By:   /s/ J.T. Taylor         Name:   J.T. Taylor        Title:   Senior
Vice President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            UBS LOAN FINANCE LLC
      By:   /s/ Mary E. Evans         Name:   Mary E. Evans        Title:  
Associate Director     

                  By:   /s/ Irja R. Otsa         Name:   Irja R. Otsa       
Title:   Associate Director     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            THE INTERNATIONAL BANK OF MIAMI, N.A.
      By:   /s/ Panayiotis Ch. Zotos         Name:   Panayiotis Ch. Zotos       
Title:   Senior Vice President     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages

 

--------------------------------------------------------------------------------

 

            MERRILL LYNCH BANK USA
      By:   /s/ Louis Alder         Name:   Louis Alder        Title:  
Director     

Pediatrix Medical Group, Inc.
Amendment No. 3 to Credit Agreement
Signature Pages